# Charles M. Perou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-m-perou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 260,833 |
| Field | Breast Cancer Treatment Studies |
| h-index | 194 |
| i10-index | 576 |
| Last Known Institution | University of North Carolina at Chapel Hill |
| OpenAlex ID | https://openalex.org/A5062498736 |
| ORCID iD | https://orcid.org/0000-0001-9827-2247 |
| Works | 2,041 |

## Researcher papers

Showing 12 of 21.

- [Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications](https://scholariq.org/papers/gene-expression-patterns-of-breast-carcinomas-distinguish-tumor-subclasses-with/)
- [The Somatic Genomic Landscape of Glioblastoma](https://scholariq.org/papers/the-somatic-genomic-landscape-of-glioblastoma/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study](https://scholariq.org/papers/race-breast-cancer-subtypes-and-survival-in-the-carolina-breast-cancer-study/)
- [Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013](https://scholariq.org/papers/personalizing-the-treatment-of-women-with-early-breast-cancer-highlights-of-the/)
- [Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma](https://scholariq.org/papers/immunohistochemical-and-clinical-characterization-of-the-basal-like-subtype-of/)
- [Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma](https://scholariq.org/papers/identification-of-a-cpg-island-methylator-phenotype-that-defines-a-distinct/)
- [The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes](https://scholariq.org/papers/the-triple-negative-paradox-primary-tumor-chemosensitivity-of-breast-cancer/)
- [Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer](https://scholariq.org/papers/comprehensive-molecular-portraits-of-invasive-lobular-breast-cancer/)
- [Proteogenomics connects somatic mutations to signalling in breast cancer](https://scholariq.org/papers/proteogenomics-connects-somatic-mutations-to-signalling-in-breast-cancer/)
- [Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update](https://scholariq.org/papers/estrogen-and-progesterone-receptor-testing-in-breast-cancer-asco-cap-guideline/)
- [The molecular portraits of breast tumors are conserved across microarray platforms](https://scholariq.org/papers/the-molecular-portraits-of-breast-tumors-are-conserved-across-microarray/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [University of North Carolina at Chapel Hill](https://scholariq.org/institutions/university-of-north-carolina-at-chapel-hill/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.